blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1363925

EP1363925 - MACROLIDE ANTIBIOTICS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.09.2007
Database last updated on 02.11.2024
Most recent event   Tooltip12.12.2008Lapse of the patent in a contracting state
New state(s): CY
published on 14.01.2009  [2009/03]
Applicant(s)For all designated states
GLAXO GROUP LIMITED
Glaxo Wellcome House, Berkeley Avenue
Greenford, Middlesex UB6 0NN / GB
For all designated states
GlaxoSmithKline istrazivacki centar Zagreb d.o.o.
Prilaz Baruna Filipovica 29
10000 Zagreb / HR
[N/P]
Former [2007/14]For all designated states
GLAXO GROUP LIMITED
Glaxo Wellcome House, Berkeley Avenue
Greenford, Middlesex UB6 ONN / GB
For all designated states
GlaxoSmithKline istrazivacki centar Zagreb d.o.o.
Prilaz Baruna Filipovica 29
10000 Zagreb / HR
Former [2006/46]For all designated states
GLAXO GROUP LIMITED
Glaxo Wellcome House, Berkeley Avenue
Greenford, Middlesex UB6 ONN / GB
For all designated states
PLIVA D.D.
Ulica grada Vukovara 49
10000 Zagreb / HR
Former [2004/30]For all designated states
GLAXO GROUP LIMITED
Glaxo Wellcome House Berkeley Avenue
Greenford, Middlesex UB6 ONN / GB
For all designated states
PLIVA d.d.
Ulica grada Vukovara 49
10000 Zagreb / HR
Former [2003/48]For all designated states
GLAXO GROUP LIMITED
Glaxo Wellcome House Berkeley Avenue
Greenford, Middlesex UB6 ONN / GB
Inventor(s)01 / ANDREOTTI, Daniele, GlaxoSmithKline SpA
Via Alessandro Fleming, 2
I-37100 Verona / IT
02 / ARISTA, Luca, GlaxoSmithKline SpA
Via Alessandro Fleming, 2
I-37100 Verona / IT
03 / BIONDI, Stefano, GlaxoSmithKline SpA
Via Alessandro Fleming, 2
I-37100 Verona / IT
04 / CARDULLO, Francesca, GlaxoSmithKline SpA
Via Alessandro Fleming, 2
I-37100 Verona / IT
05 / DAMIANI, Frederica, GlaxoSmithKline SpA
Via Alessandro Fleming, 2
I-37100 Verona / IT
06 / LOCIURO, Sergio, GlaxoSmithKline SpA
Via Alessandro Fleming, 2
I-37100 Verona / IT
07 / MARCHIORO, Carla, GlaxoSmithKline SpA
Via Alessandro Fleming, 2
I-37100 Verona / IT
08 / MERLO, Giancarlo, GlaxoSmithKline SpA
Via Alessandro Fleming, 2
I-37100 Verona / IT
09 / MINGARDI, Anna, GlaxoSmithKline SpA
Via Alessandro Fleming, 2
I-37100 Verona / IT
10 / NICCOLAI, Daniela, GlaxoSmithKline SpA
Via Alessandro Fleming, 2
I-37100 Verona / IT
11 / PAIO, Alfredo, GlaxoSmithKline SpA
Via Alessandro Fleming, 2
I-37100 Verona / IT
12 / PIGA, Elisabetta, GlaxoSmithKline SpA
Via Alessandro Fleming, 2
I-37100 Verona / IT
13 / POZZAN, Alfonso, GlaxoSmithKline SpA
Via Alessandro Fleming 2
I-37100 Verona / IT
14 / SERI, Catia, GlaxoSmithKline SpA
Via Alessandro Fleming, 2
I-37100 Verona / IT
15 / TARSI, Luca, GlaxoSmithKline SpA
Via Alessandro Fleming, 2
I-37100 Verona / IT
16 / TERRENI, Silvia, GlaxoSmithKline SpA
Via Alessandro Fleming 2
I-37100 Verona / IT
17 / TIBASCO, Jessica, GlaxoSmithKline SpA
Via Alessandro Fleming, 2
I-37100 Verona / IT
18 / CIRACO, Manuela, c/o BPB Italia S.p.A.
Strada Provinciale Cerca, 9
20090 Settala / IT
 [2003/48]
Representative(s)Gladwin, Amanda Rachel, et al
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[N/P]
Former [2005/29]Gladwin, Amanda Rachel, et al
GlaxoSmithKline, Corporate Intellectual Property, CN925.1, 980 Great West Road
Brentford, Middlesex TW8 9GS / GB
Former [2005/24](deleted)
Former [2004/22]Schrell, Andreas, Dr.
Gleiss & Grosse Leitzstrasse 45
70469 Stuttgart / DE
Former [2003/48]Giddings, Peter John
GlaxoSmithkline Corporate Intellectual Property (CN925.1) 980 Great West Road
Brentford, Middlesex TW8 9EP / GB
Application number, filing date01271380.620.12.2001
[2003/48]
WO2001GB05665
Priority number, dateGB2000003130921.12.2000         Original published format: GB 0031309
GB2001002627701.11.2001         Original published format: GB 0126277
GB2001002627601.11.2001         Original published format: GB 0126276
[2003/48]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0250091
Date:27.06.2002
Language:EN
[2002/26]
Type: A1 Application with search report 
No.:EP1363925
Date:26.11.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 27.06.2002 takes the place of the publication of the European patent application.
[2003/48]
Type: B1 Patent specification 
No.:EP1363925
Date:15.11.2006
Language:EN
[2006/46]
Type: B8 Corrected title page of specification 
No.:EP1363925
Date:25.04.2007
[2007/17]
Search report(s)International search report - published on:EP27.06.2002
ClassificationIPC:C07H17/08, A61K31/70
[2003/48]
CPC:
C07H17/08 (EP,KR,US); A61K9/0019 (EP,US); A61K9/2018 (EP,US);
A61P31/04 (EP); A61P31/10 (EP); Y02P20/55 (EP,US)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/48]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SI18.06.2003
TitleGerman:MAKROLIDANTIBIOTIKA[2003/48]
English:MACROLIDE ANTIBIOTICS[2003/48]
French:ANTIBIOTIQUES A BASE DE MACROLIDES[2003/48]
Entry into regional phase18.06.2003National basic fee paid 
18.06.2003Designation fee(s) paid 
18.06.2003Examination fee paid 
Examination procedure17.07.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
18.06.2003Examination requested  [2003/48]
20.01.2005Despatch of a communication from the examining division (Time limit: M06)
13.06.2005Reply to a communication from the examining division
24.06.2005Despatch of a communication from the examining division (Time limit: M06)
21.12.2005Reply to a communication from the examining division
09.02.2006Communication of intention to grant the patent
09.06.2006Fee for grant paid
09.06.2006Fee for publishing/printing paid
Opposition(s)17.08.2007No opposition filed within time limit [2007/43]
Fees paidRenewal fee
03.12.2003Renewal fee patent year 03
13.10.2004Renewal fee patent year 04
05.12.2005Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT15.11.2006
CH15.11.2006
CY15.11.2006
FI15.11.2006
LI15.11.2006
NL15.11.2006
TR15.11.2006
IE20.12.2006
LU20.12.2006
MC31.12.2006
DK15.02.2007
SE15.02.2007
GR16.02.2007
PT16.04.2007
[2009/03]
Former [2008/37]AT15.11.2006
CH15.11.2006
FI15.11.2006
LI15.11.2006
NL15.11.2006
TR15.11.2006
IE20.12.2006
LU20.12.2006
MC31.12.2006
DK15.02.2007
SE15.02.2007
GR16.02.2007
PT16.04.2007
Former [2008/19]AT15.11.2006
CH15.11.2006
FI15.11.2006
LI15.11.2006
NL15.11.2006
IE20.12.2006
MC31.12.2006
DK15.02.2007
SE15.02.2007
GR16.02.2007
PT16.04.2007
Former [2007/48]AT15.11.2006
CH15.11.2006
FI15.11.2006
LI15.11.2006
NL15.11.2006
IE20.12.2006
MC31.12.2006
DK15.02.2007
SE15.02.2007
PT16.04.2007
Former [2007/37]AT15.11.2006
CH15.11.2006
FI15.11.2006
LI15.11.2006
NL15.11.2006
MC31.12.2006
DK15.02.2007
SE15.02.2007
PT16.04.2007
Former [2007/36]AT15.11.2006
CH15.11.2006
FI15.11.2006
LI15.11.2006
NL15.11.2006
SE15.02.2007
PT16.04.2007
Former [2007/30]AT15.11.2006
CH15.11.2006
FI15.11.2006
LI15.11.2006
NL15.11.2006
SE15.02.2007
Former [2007/28]AT15.11.2006
FI15.11.2006
NL15.11.2006
SE15.02.2007
Former [2007/25]FI15.11.2006
SE15.02.2007
Cited inInternational search[A]FR2732684  (ROUSSEL UCLAF [FR]);
 [A]US5747467  (AGOURIDAS CONSTANTIN [FR], et al);
 [A]WO9921870  (TAISHO PHARMACEUTICAL CO LTD [JP], et al);
 [A]WO9921869  (TAISHO PHARMACEUTICAL CO LTD [JP], et al);
 [A]WO0044761  (PFIZER PROD INC [US], et al);
 [PDA]EP1114826  (PFIZER PROD INC [US])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.